Oncolytics Biotech Inc (ONCY)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $48.51M
Last updated: Nov 17, 2026 at 11:05 AM ET
Oncolytics Biotech Inc (ONCY) Competitors
The companies most similar to Oncolytics Biotech are Cardiff Oncology (CRDF), OS Therapies (OSTX) and Connect Biopharma Holdings (CNTB). By market cap, Oncolytics Biotech ranks 5th of the 13 companies on this page; Tiziana Life Sciences (TLSA) is the largest at $72.53M.
Peer Comparison
ONCY's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Oncolytics Biotech (ONCY) | $48.51M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Cardiff Oncology Inc (CRDF) | $56.49M | N/A | 115.5x | 0.0% | N/A | -14.1% | 0.00% |
| OS Therapies Incorporated (OSTX) | $34.87M | N/A | N/A | 0.0% | 218.0% | 0.0% | 0.00% |
| Connect Biopharma Holdings Ltd (CNTB) | $42.65M | N/A | 13.6x | 0.0% | N/A | 5667.0% | 0.00% |
| Champions Oncology Inc (CSBR) | $65.49M | N/A | 1.0x | -1.9% | N/A | 8.8% | 0.00% |
| XBiotech Inc (XBIT) | $59.76M | N/A | N/A | 0.0% | N/A | -93.3% | 0.00% |
| Mural Oncology plc (MURA) | $35.38M | N/A | N/A | 0.0% | -173.6% | 0.0% | 0.00% |
| Instil Bio Inc. (TIL) | $41.23M | N/A | N/A | 0.0% | -11.9% | 0.0% | 0.00% |
| Plus Therapeutics Inc (PSTV) | $26.64M | N/A | 2.0x | -230.2% | -827.8% | -2.9% | 0.00% |
| Werewolf Therapeutics Inc (HOWL) | $47.64M | N/A | 2.3x | -164.8% | N/A | -100.0% | 0.00% |
| Tiziana Life Sciences Ltd (TLSA) | $72.53M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| ImageneBio, Inc. (IMA) | $43.22M | N/A | 68.5x | 0.0% | N/A | 0.0% | 0.00% |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO) | $36.15M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Peer median | $42.93M | N/A | 8.0x | 0.0% | -92.8% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Oncolytics Biotech, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Cardiff Oncology Inc (CRDF) | Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops drugs for the treatment of cancer. | CRDF competitors |
| OS Therapies Incorporated (OSTX) | OS Therapies Incorporated is a pioneering biopharmaceutical company committed to developing innovative treatments for unmet medical needs... | OSTX competitors |
| Connect Biopharma Holdings Ltd (CNTB) | Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, is focused on the discovery and development of immune modulators... | CNTB competitors |
| Champions Oncology Inc (CSBR) | Champions Oncology, Inc. develops and sells technology products and solutions to customize the development and use of cancer drugs in the United States. | CSBR competitors |
| XBiotech Inc (XBIT) | XBiotech Inc., a biopharmaceutical company, discovers, develops and markets True Human monoclonal antibodies for the treatment of various diseases. | XBIT competitors |
| Mural Oncology plc (MURA) | Mural Oncology plc is a pioneering biotechnology company dedicated to developing targeted therapies for solid tumors... | |
| Instil Bio Inc. (TIL) | Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer patients. | TIL competitors |
| Plus Therapeutics Inc (PSTV) | Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing... | PSTV competitors |
| Werewolf Therapeutics Inc (HOWL) | Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapies designed to boost the body's immune system for the treatment of cancer. | HOWL competitors |
| Tiziana Life Sciences Ltd (TLSA) | Tiziana Life Sciences Plc, a clinical-stage biotechnology company, focuses on the discovery and development of molecules and related diagnostics to treat... | |
| ImageneBio, Inc. (IMA) | ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases. | IMA competitors |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO) | Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human... | TELO competitors |
Frequently Asked Questions About ONCY
Who are Oncolytics Biotech's main competitors?
The companies most similar to Oncolytics Biotech include Cardiff Oncology (CRDF), OS Therapies (OSTX), Connect Biopharma Holdings (CNTB), Champions Oncology (CSBR) and XBiotech (XBIT), listed from the closest match.
Who is Oncolytics Biotech's biggest competitor?
Tiziana Life Sciences (TLSA) is the largest of the similar companies at $72.53M; Cardiff Oncology (CRDF) is the closest match by business profile, size, sector and industry.
How does ONCY stock compare with its competitors?
ONCY's net margin is 0.0% against a peer median of 0.0%.
Which of Oncolytics Biotech's competitors pays a higher dividend?
Oncolytics Biotech pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Oncolytics Biotech bigger than its competitors?
No. Oncolytics Biotech is 5th by market cap among the 13 companies on this page; the largest is Tiziana Life Sciences (TLSA) at $72.53M.
ONCY pages: Overview, Competitors